跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,974 条关于
“spleen tyrosine kinase”
全部
12,974
临床试验
10,370
药物
527
机构
33
资讯
2,044
去年
TAVALISSE® (Fostamatinib) Approved in Mexico for Chronic ITP Treatment
去年
Rigel's Fostamatinib Enrolls First Patient in Phase I Sickle Cell Disease Trial
去年
Fostamatinib Fails to Improve Outcomes in Hypoxemic COVID-19 Patients
去年
Hutchison MediPharma's Sovleplenib Demonstrates Efficacy in Autoimmune Disorders
8个月前
HUTCHMED's Sovleplenib Meets Primary Endpoint in Phase III Trial for Warm Autoimmune Hemolytic Anemia
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
11个月前
Rigel Pharmaceuticals Reports Strong Growth Across Oncology Portfolio with 44% Revenue Increase
4个月前
HUTCHMED's Sovleplenib Receives Priority Review and Breakthrough Designation in China for Rare Blood Disorder
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
第 1 页,共 205 页
上一页
下一页